WEALTH EFFECTS LLC logo

WEALTH EFFECTS LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for WEALTH EFFECTS LLC with $310.3M in long positions as of Q3 2025, 29% allocated to Technology, and 48% concentrated in top 10 positions.

Portfolio Value
$310.3M
Top 10 Concentration
48%
Top Sector
Technology (29%)
US Exposure
88%
Market Cap Focus
Mega Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Technology: 29.30%TechnologyHealthcare: 18.00%HealthcareETF: 16.70%ETFFinancial Services: 8.00%Communication Services: 6.60%Consumer Cyclical: 6.20%Industrials: 5.30%Energy: 2.30%Utilities: 2.00%Consumer Defensive: 1.70%Real Estate: 0.30%Basic Materials: 0.20%
Technology
29.30%
Healthcare
18.00%
ETF
16.70%
Financial Services
8.00%
Communication Services
6.60%
Consumer Cyclical
6.20%
Industrials
5.30%
Energy
2.30%
Utilities
2.00%
Consumer Defensive
1.70%
Real Estate
0.30%
Basic Materials
0.20%

Industry Breakdown

59 industries across all sectors

ETF: 16.74%ETFSemiconductors: 12.85%SemiconductorsDrug Manufacturers - Specialty & Generic: 11.37%Drug Manufacturers - Specialty & GenericConsumer Electronics: 6.69%Internet Content & Information: 5.25%Software - Infrastructure: 4.82%Specialty Retail: 4.62%Banks - Diversified: 4.04%Drug Manufacturers - General: 2.91%Biotechnology: 2.40%Software - Application: 2.14%Asset Management: 1.76%Aerospace & Defense: 1.27%Electrical Equipment & Parts: 1.24%Information Technology Services: 1.23%44 more: 17.36%44 more
ETF
ETF
16.74%
Semiconductors
Technology
12.85%
Drug Manufacturers - Specialty & Generic
Healthcare
11.37%
Consumer Electronics
Technology
6.69%
Internet Content & Information
Communication Services
5.25%
Software - Infrastructure
Technology
4.82%
Specialty Retail
Consumer Cyclical
4.62%
Banks - Diversified
Financial Services
4.04%
Drug Manufacturers - General
Healthcare
2.91%
Biotechnology
Healthcare
2.40%
Software - Application
Technology
2.14%
Asset Management
Financial Services
1.76%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 45.63%Mega Cap (> $200B)Large Cap ($10B - $200B): 14.93%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 6.08%Small Cap ($300M - $2B): 12.65%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 0.33%Nano Cap (< $50M): 0.37%N/A (ETF or Unknown): 20.01%N/A (ETF or Unknown)
Mega Cap (> $200B)
45.63%
Large Cap ($10B - $200B)
14.93%
Mid Cap ($2B - $10B)
6.08%
Small Cap ($300M - $2B)
12.65%
Micro Cap ($50M - $300M)
0.33%
Nano Cap (< $50M)
0.37%
N/A (ETF or Unknown)
20.01%

Portfolio Concentration

Top 10 Holdings %
47.66%
Top 20 Holdings %
58.63%
Top 50 Holdings %
75.5%
Top 100 Holdings %
88.52%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
88.2%
International
11.8%
Countries
4
Largest Int'l Market
Ireland - 11.26%
United States of America
88.20% ($273.7M)
210 holdings
Ireland
11.26% ($35.0M)
1 holdings
Canada
0.41% ($1.3M)
4 holdings
Uruguay
0.13% ($387.9K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
14 quarters
Avg. Top 20
13.3 quarters
Avg. All Positions
10.1 quarters
Median Holding Period
11 quarters
Persistence Rate
80.56%
Persistent Holdings Weight
94.24%
Persistent Positions
174
Longest Held
VISA Inc. logo
VISA Inc.V - 15 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.12%
Avg. Position Weight
0.46%
Largest Position
Avadel Pharmaceuticals plc Ordinary Share logo
Avadel Pharmaceuticals plc Ordinary ShareAVDL - 11.26%
Largest Ownership Stake
Avadel Pharmaceuticals plc Ordinary Share logo
Avadel Pharmaceuticals plc Ordinary ShareAVDL - 2.36%
Avg. Ownership Stake
0.33%
Ownership Stake >5%
0
Ownership Stake >1%
1

Historical (Since Q4 2021)

Avg. New Position
0.36%
Avg. Ownership Stake
0.39%
Largest Position
Avadel Pharmaceuticals plc Ordinary Share logo
Avadel Pharmaceuticals plc Ordinary ShareAVDL - 17.18% (Q2 2023)
Largest Ownership Stake
Avadel Pharmaceuticals plc Ordinary Share logo
Avadel Pharmaceuticals plc Ordinary ShareAVDL - 4.38% (Q2 2022)

Portfolio Turnover

Current Quarter

Turnover Ratio
4.3%
Value Traded
$13.46M
Positions Added
12
Positions Exited
12

Historical (Since Q4 2021)

Avg. Turnover Ratio
8.3%
Avg. Positions Added
24
Avg. Positions Exited
15
Highest Turnover
50.0%
Q4 2021
Lowest Turnover
3.5%
Q2 2025

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.